/PRNewswire/ Scientists from the Viennese biotech company BlueSky Immunotherapies GmbH (Ltd.) have used their viral vector platform delNS to treat sarcoids.
VIENNA, Dec. 10, 2021 /PRNewswire/ Scientists from the Viennese biotech company BlueSky Immunotherapies GmbH (Ltd.) have used their viral vector platform delNS to treat sarcoids in horses.
/PRNewswire/ Scientists from the Viennese biotech company BlueSky Immunotherapies GmbH (Ltd.) have used their viral vector platform delNS to treat sarcoids.
Austrian cryptocurrency Rotharium soon available at Bitcoin ATMs kosmo.at - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kosmo.at Daily Mail and Mail on Sunday newspapers.